IP Library Granted Patent US 10,328,203
Granted Patent B2
US 10,328,203 · App. 15/298,456 · Granted Jun 25, 2019

Sensor system for drug delivery device, drug delivery device having the same and method of using the same

Inventors: Scott Albert Uhland (San Jose, CA); Eric Peeters (Mountain View, CA); Bryan Thomas Preas (Battle Ground, OR); Joerg Martini (San Francisco, CA)
Assignee: PALO ALTO RESEARCH CENTER INCORPORATED
A61M5/1723A61M5/1684A61M5/16836A61M2205/3303A61M2205/3306A61M2205/3317A61M2205/3368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,328,203
App. No.
15/298,456
Granted
Jun 25, 2019
Kind
B2
Abstract

A system for use with a drug delivery device includes a sensor unit and a deactivation unit operatively coupled to an output of the sensor unit and to a drug-retaining region of the drug delivery device, wherein the drug-retaining region contains a drug. The sensor unit is configured to detect a characteristic of a local environment and generate an output corresponding to a value of the detected characteristic. The deactivation unit is configured to render the drug ineffective when the output of the sensor unit satisfies a predetermined condition.

Claims (37)

1. A system for use with a drug delivery device having a drug in a reservoir, the system comprising:

a sensor unit configured to detect a characteristic in a local environment and generate an output corresponding to a value of the detected characteristic; and

a deactivation unit operatively coupled to the sensor unit and to the reservoir, the deactivation unit having control circuitry and an energy source, the control circuitry configured to initiate application of energy from the energy source to the reservoir;

wherein the control circuitry is configured to apply the energy to the reservoir to neutralize the drug in the reservoir when the sensor unit detects a condition in the local environment using the characteristic of the local environment.

2. The system of claim 1 , wherein the sensor unit configured to detect a condition in the local environment detects a characteristic of a user.

3. The system of claim 2 , wherein the sensor unit configured to detect a condition in the local environment further comprises a user engageable element coupled to the drug delivery device.

4. The system of claim 1 , wherein the sensor unit configured to detect a condition in the local environment further comprises at least one characteristic in the local environment selected from the group consisting of a mechanical characteristic, a thermal characteristic, an electrical characteristic, an optical characteristic and a chemical characteristic.

5. The system of claim 1 , wherein the condition is satisfied when the value of the detected characteristic in the local environment is outside a predetermined range.

6. The system of claim 1 , wherein the condition is satisfied when the value of the detected characteristic in the local environment is within a predetermined range.

7. The system of claim 1 , wherein the condition is satisfied when a rate at which the value of the detected characteristic in the local environment changes is outside a predetermined range.

8. The system of claim 1 , wherein the condition is satisfied when a user engages with a user engageable element coupled to the drug delivery device.

9. The system of claim 1 , wherein the drug is transportable from the reservoir to a user upon application of energy from the energy source to the reservoir.

10. The drug delivery device of claim 9 , wherein the deactivation unit is further configured to discontinue the application of energy from the energy source to the reservoir when the output of the sensor unit satisfies the condition.

11. A system for use with a drug delivery device having a drug in a reservoir, the system comprising:

a sensor unit configured to detect a characteristic in a local environment and generate an output corresponding to a value of the detected characteristic; and

a deactivation unit operatively coupled to the sensor unit and to the reservoir, the deactivation unit having control circuitry and a capsule, the control circuitry configured to expose the capsule to the reservoir;

wherein the control circuitry is configured to expose the capsule to the reservoir to neutralize the drug when the sensor unit detects a condition in the local environment using the characteristic of the local environment.

12. The system of claim 11 , wherein the drug delivery device includes at least one selected from the group consisting of an inhaler, a syringe, an intravenous bag, an implanted drug delivery system, a transdermal patch, a pill bottle, a liquid medicine bottle and an eyedropper.

13. The system of claim 11 , further comprising a housing, wherein the reservoir is located within the housing, and wherein the sensor unit comprises at least one sensor coupled to the housing.

14. The system of claim 11 , wherein the capsule is degradable and contains material to neutralize the drug in the reservoir when the condition is satisfied.

15. The system of claim 11 , further comprising a user engageable element that is detectable by the sensor unit when a user engages with the user engageable element.

16. A method for using of a drug delivery device having a reservoir operatively coupled to a deactivation unit and a sensor unit, the reservoir containing a drug, the deactivation unit having control circuitry and an energy source, the method comprising:

detecting, using the sensor unit, a characteristic in a local environment;

outputting, at the sensor unit, a signal corresponding to the detected characteristic;

receiving the output value of the signal corresponding to the detected characteristic at the control circuitry; and

responsive to receiving the output value at the control circuitry, outputting a signal from the control circuitry to the energy source and applying energy from the energy source to the reservoir to neutralize the drug when the sensor unit outputs a signal indicating detection of a condition in the local environment using the characteristic in the local environment.

17. The method of claim 16 , wherein said outputting outputs the signal when the value of the detected characteristic in the local environment is outside a predetermined range.

18. The method of claim 16 , wherein said outputting outputs the signal when the value of the detected characteristic in the local environment is within a predetermined range.

19. The method of claim 16 , wherein said detecting detects at least one characteristic in a local environment selected from the group consisting of a mechanical characteristic, a thermal characteristic, an electrical characteristic, an optical characteristic and a chemical characteristic.

20. A method of use of a drug delivery device having a reservoir operatively coupled to a deactivation unit and a sensor unit, the reservoir containing a drug, the deactivation unit having control circuitry and a capsule, the control circuitry configured to expose the capsule to the reservoir, the method comprising:

detecting, using the sensor unit, a characteristic in a local environment;

outputting, at the sensor unit, an output value corresponding to the detected characteristic;

receiving the output value at the control circuitry; and

responsive to receiving the output value corresponding to the detected characteristic at the control circuitry, outputting a signal from the control circuitry to the energy source and exposing the capsule to the reservoir to neutralize a drug in the reservoir when the sensor unit outputs an output value indicating the detection of a condition in the local environment using the characteristic of the local environment.

21. The method of claim 20 , wherein said outputting outputs the output value when the output value of the detected characteristic in the local environment is outside a predetermined range.

22. The method of claim 20 , wherein said outputting outputs the output value when the output value of the detected characteristic in the local environment is within a predetermined range.

23. The method of claim 20 , wherein said detecting detects at least one characteristic in a local environment selected from the group consisting of a mechanical characteristic, a thermal characteristic, an electrical characteristic, an optical characteristic and a chemical characteristic.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: UHLAND, SCOTT ALBERT; PEETERS, ERIC; PREAS, BRYAN THOMAS; MARTINI, JOERG
To: PALO ALTO RESEARCH CENTER INCORPORATED
Reel/Frame 040074/0190 →
Continuity (2)
Continuation 12356824 · Jan 21, 2009
Related Publication 20170035970A1 · Feb 9, 2017